Porcine Vaccine Market Size 2025-2029
The porcine vaccine market size is forecast to increase by USD 763.3 million, at a CAGR of 6.4% between 2024 and 2029.
The increasing prevalence of epidemic porcine diseases serves as a fundamental driver for the global porcine vaccine market, necessitating the use of advanced veterinary vaccines to safeguard swine populations. This need is compounded by the growing demand for the pork meat market and its derivatives, a key trend that encourages greater investment in preventative health measures to boost herd productivity and efficiency. The development of specialized products, including those for the foot and mouth disease vaccines market, reflects the industry's focus on comprehensive disease control. These dynamics underscore the critical role of vaccination in supporting a stable and healthy global pork supply chain.However, this growth trajectory is met with the significant challenge of a lack of trained veterinary doctors. This shortage hampers the accurate execution of swine disease diagnostics and the effective implementation of complex vaccination protocols, which are essential for managing herd health. The scarcity of skilled professionals directly impacts the ability to manage the sensitive vaccine cold chain and ensure optimal vaccine efficacy. This operational gap poses a considerable challenge to the widespread adoption and success of advanced solutions within the porcine vaccine market, affecting everything from pathogen-specific immunity to the reliability of mass vaccination programs.
What will be the Size of the Porcine Vaccine Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019 - 2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
Market activity is characterized by continuous innovation in veterinary vaccines, moving toward solutions that offer broader pathogen-specific immunity. The development of multivalent vaccines and advanced adjuvant technology reflects a focus on improving vaccine efficacy and streamlining mass vaccination programs to enhance herd productivity metrics. This strategic direction aligns with broader trends observed in the influenza vaccine market, where combination products are becoming standard. These efforts are geared toward providing more comprehensive and efficient tools for herd health management.The focus on biosecurity protocols is intensifying across the industry, driving demand for vaccines that contribute to viral shedding reduction. Advances in antigen technology and the adoption of intradermal application methods are key areas of current development, aiming to improve animal welfare standards and ensure the safety of the global pork meat market. These technological shifts are critical for building resilience against endemic and emerging diseases, thereby securing the international food supply chain.
How is this Porcine Vaccine Industry segmented?
The porcine vaccine industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019 - 2023 for the following segments.
- Product
- Distribution channel
- Veterinary clinics
- Veterinary hospitals
- Pharmacies and drug stores
- Others
- Route of administration
- Geography
- North America
- Europe
- Germany
- UK
- France
- Italy
- The Netherlands
- Spain
- Asia
- Rest of World (ROW)
By Product Insights
The intravenous segment is estimated to witness significant growth during the forecast period.
The intravenous route of administration, which involves direct injection into a vein, is not a commercially viable or accepted method for swine vaccination. This approach is impractical for modern pork production, where the efficient and safe vaccination of large herds is paramount. The procedure is technically difficult, time-consuming, and requires a high level of skill, making it unsuitable for mass application in a commercial farm environment.
Furthermore, this method induces significant stress on the animals and carries a substantially higher risk of systemic adverse reactions, such as anaphylactic shock, compared to other routes. Consequently, veterinary vaccine manufacturers do not develop or license porcine vaccines for intravenous administration. Regulatory bodies have not approved this route, and industry research is instead focused on safer and more effective methods like intramuscular or intradermal application, which are better suited for achieving herd immunity.
Request Free Sample
The Intravenous segment was valued at USD 1.1 billion in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 44.6% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Request Free Sample
The porcine vaccine market in North America is defined by its maturity and high level of organization. The region's growth is supported by a well-established and technologically advanced swine production industry that relies on vaccination as a core component of herd health management. The presence of large-scale, integrated farming operations creates a consistent demand for vaccines to control endemic diseases that impact productivity. High animal healthcare expenditure, reflecting a strong emphasis on animal welfare and food safety, further sustains market expansion in North America.
A significant driver in the North America market is the proactive approach to disease prevention and biosecurity, shaped by the constant threat of foreign animal diseases. Animal healthcare expenditure in the region's developed economies is substantial, with total spending reaching approximately USD 152 billion in one major country in 2024. This investment supports robust disease surveillance, research into novel vaccines, and the implementation of comprehensive vaccination programs, ensuring the region remains a dominant force in the global market.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The global porcine vaccine market is pivotal, with its role of vaccines in global food security becoming increasingly prominent. The development of vaccines for disease management is driven by the significant economic impact of PRRS on swine production and the ongoing challenges in developing effective ASF vaccines. Effective strategies for controlling porcine epidemic diseases are essential, combining vaccination with stringent biosecurity measures to prevent ASF transmission. The industry is focused on swine influenza virus vaccine development and managing viral mutations with updated vaccines. Concurrently, advancements in porcine vaccine adjuvant technology are crucial for improving protective immunity in swine herds, but gaining regulatory approval for novel swine vaccines remains a key procedural step for market entry.Operational excellence in vaccine deployment involves a comparative analysis of live vs inactivated vaccines to determine the best approach for specific herd health goals. Innovations like needle-free intradermal vaccination systems for pigs are key to improving animal welfare during vaccination. For tailored solutions, autogenous vaccine use in commercial swine farms is gaining traction. The sector is also exploring oral vaccination strategies for large herds to enhance efficiency. A critical success factor is monitoring vaccine efficacy in field conditions, which ensures desired outcomes such as reducing antibiotic use through vaccination and minimizes any negative impact of vaccination on pork quality. All these efforts depend on robust cold chain logistics for porcine vaccines to maintain product integrity.
What are the key market drivers leading to the rise in the adoption of Porcine Vaccine Industry?
- The market's growth is primarily driven by the increasing prevalence of various porcine diseases.
The increasing prevalence of epidemic porcine diseases remains a significant driver for the market. Outbreaks of highly contagious and economically damaging illnesses, such as porcine reproductive and respiratory syndrome (PRRS) and classical swine fever (CSF), create a sustained demand for effective preventative measures. PRRS leads to significant reproductive failure and respiratory issues, while CSF is a lethal viral disease with a mortality rate of 100%, capable of causing substantial economic losses. The ongoing presence of such diseases necessitates robust herd health management strategies, where vaccination is a critical component for minimizing losses and maintaining herd productivity metrics. The development of vaccines for disease management is therefore a primary focus for producers aiming to mitigate these threats.Growth in research and development expenditure is another key factor shaping the market. Increased investment is enabling the creation of more sophisticated vaccines, including recombinant vaccines, multivalent vaccines, and those with advanced adjuvant technology. This focus on innovation is driven by the need to address challenges like viral strain variation and to improve vaccine efficacy and safety profiles. By developing next-generation products, manufacturers are offering solutions that provide broader, more durable pathogen-specific immunity. These advancements not only enhance animal welfare but also deliver greater value to producers by simplifying vaccination schedules and improving overall herd health, thereby supporting the continued expansion of the market.
What are the market trends shaping the Porcine Vaccine Industry?
- A significant upcoming trend is the growing demand for pork and gelatin, which is heightening the focus on swine health and productivity.
The rising global demand for products from the pork meat market and the increasing use of gelatin across various industries are creating a strong tailwind for the porcine vaccine market. As pork consumption grows, there is a heightened emphasis on ensuring the health and productivity of swine herds, leading to greater investment in veterinary vaccines. This dual demand from the food and pharmaceutical sectors, which use gelatin derived from pigs, incentivizes producers to maintain healthy livestock. This, in turn, fuels advancements in antigen technology, with a focus on developing more effective solutions, such as dna vaccines and recombinant vaccines, to protect against a wide array of swine diseases and improve herd productivity metrics.Increasing government initiatives aimed at supporting the animal husbandry sector are also fostering a favorable environment for market growth. Recognizing the importance of animal health to national food security and the rural economy, public bodies are providing funding and support for disease surveillance systems and biosecurity protocols. These programs often encourage the adoption of preventative health measures, including mass vaccination programs. By 2050, it is projected that one-fourth of the population in some developed nations will be over 60, indirectly increasing the focus on stable and safe food supplies, which reinforces the need for robust animal health frameworks and supports sustained investment in the sector.
What challenges does the Porcine Vaccine Industry face during its growth?
- A key challenge affecting industry growth is the widespread lack of sufficiently trained veterinary professionals.
A significant challenge facing the market is the lack of trained veterinary professionals with specialized knowledge in swine health. The effective use of porcine vaccines depends on accurate swine disease diagnostics, correct sample collection, and the selection of appropriate vaccines for specific pathogens. Furthermore, administering these vaccines and managing the logistics, such as the vaccine cold chain, requires considerable expertise. For instance, some live vaccines for Classical Swine Fever require storage at -15 degrees C, a requirement that cannot be met without proper facilities and trained personnel. The shortage of skilled veterinarians capable of performing these tasks limits the adoption of advanced vaccination programs and negatively impacts herd health management, particularly in emerging economies.The chance of a reverse reaction from vaccines, although rare, presents another challenge for the industry. Live attenuated vaccines, while highly effective at stimulating a robust immune response, carry an inherent risk of reverting to a virulent form, potentially causing the disease they are designed to prevent. This risk necessitates rigorous testing and a robust vaccine safety profile before regulatory approval. Any such adverse event can undermine producer confidence and lead to hesitation in adopting certain types of vaccines. This challenge requires continuous innovation in vaccine development, such as the creation of subunit vaccines and DNA vaccines, which can offer high levels of safety and eliminate the risk of reversion, thereby improving the overall safety of vaccination protocols.
Exclusive Customer Landscape
The porcine vaccine market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the porcine vaccine market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, porcine vaccine market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
AdvaCare Pharma - The animal health portfolio includes a range of porcine vaccines formulated to protect against critical pathogens, including those responsible for circovirus and porcine reproductive and respiratory syndrome. These offerings are designed to integrate into comprehensive herd health management programs, contributing to improved animal well-being and productivity. The focus is on providing effective immunological tools that address key diseases affecting the swine industry, supporting producers in their efforts to maintain healthy and profitable operations.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- AdvaCare Pharma
- Bimeda Holdings Ltd.
- Bioveta AS
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Creative Biolabs
- Elanco Animal Health Inc.
- Endovac Animal Health
- FATRO SpA
- Formosa Biomedical Inc.
- HIPRA SA
- IDT Biologika GmbH
- Indian Immunologicals Ltd.
- Merck and Co. Inc.
- Phibro Animal Health Corp.
- Shandong Sinder Technology Co. Ltd.
- Vaxxinova International BV
- Vetoquinol SA
- Virbac Group
- Zoetis Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Porcine Vaccine Market
In June 2024, Boehringer Ingelheim introduced a vaccine with an advanced adjuvant technology designed to provide extended protection against multiple Porcine Reproductive and Respiratory Syndrome (PRRS) virus strains.In June 2024, the Canadian government announced a significant funding allocation for its African Swine Fever (ASF) Industry Preparedness Program, aimed at enhancing biosecurity, surveillance, and emergency response capabilities at the farm level.In January 2024, Ceva Sante Animale introduced a new vaccine in the United States utilizing a recombinant virus vector platform to protect against PRRS and other common porcine diseases.In July 2023, Vietnamese authorities approved the commercial use of two African Swine Fever (ASF) vaccines, marking a significant milestone in the global effort to control the spread of the devastating disease.
Research Analyst Overview
The global porcine vaccine market dynamics are shaped by intensive animal husbandry practices, where effective herd health management is crucial for herd productivity metrics. Efforts to control porcine reproductive and respiratory syndrome and porcine circovirus associated disease, which cause significant reproductive impairment and respiratory disease in pigs, involve a range of veterinary pharmaceuticals. These include live attenuated vaccines, inactivated vaccines, toxoid vaccines, and increasingly, recombinant vaccines. Comprehensive biosecurity protocols are implemented alongside vaccination to manage threats like classical swine fever virus and swine influenza. The industry is projected to expand by over 6%, driven by the need to protect livestock assets and address potential zoonotic diseases through strategic interventions.Innovation continues to alter the landscape, with a focus on enhancing vaccine efficacy and administration. The development of multivalent vaccines and the use of a virus vector platform with advanced adjuvant technology are improving the immunological response against complex pathogens. The emergence of epidemic porcine diseases, particularly African Swine Fever, has accelerated the demand for customized solutions like autogenous vaccines. Administration methods are also evolving from traditional parenteral administration via intramuscular injection to alternatives like needle-free vaccination and intradermal application, which can improve the vaccine safety profile. Ensuring pathogen-specific immunity requires precise antigen technology to counter viral strain variation, supported by serological testing and a reliable vaccine cold chain, especially for a sensitive piglet-specific vaccine.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Porcine Vaccine Market insights. See full methodology.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
279
|
|
Base year
|
2024
|
|
Historic period
|
2019 - 2023 |
|
Forecast period
|
2025-2029
|
|
Growth momentum & CAGR
|
Accelerating at a CAGR of 6.4%
|
|
Market growth 2024-2029
|
USD 763.3 million
|
|
Market structure
|
Fragmented
|
|
YoY growth 2024-2029(%)
|
6.1%
|
|
Key countries
|
US, Canada, Mexico, Germany, UK, France, Italy, The Netherlands, Spain, China, Japan, India, South Korea, Indonesia, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, South Africa, Israel, Turkey
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
What are the Key Data Covered in this Porcine Vaccine Market Research and Growth Report?
- CAGR of the Porcine Vaccine industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the porcine vaccine market growth of industry companies
We can help! Our analysts can customize this porcine vaccine market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Chart on Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
4 Market Sizing
- 4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5 Historic Market Size
- 5.1 Global Porcine Vaccine Market 2019 - 2023
- Historic Market Size - Data Table on Global Porcine Vaccine Market 2019 - 2023 ($ billion)
- 5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ billion)
- 5.3 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion)
- 5.4 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
- 6 Qualitative Analysis
- 6.1 The AI impact on Global Porcine Vaccine Market
7 Five Forces Analysis
- 7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
- 8 Market Segmentation by Product
- 8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
- 8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 8.3 Intravenous - Market size and forecast 2024-2029
- Chart on Intravenous - Market size and forecast 2024-2029 ($ billion)
- Data Table on Intravenous - Market size and forecast 2024-2029 ($ billion)
- Chart on Intravenous - Year-over-year growth 2024-2029 (%)
- Data Table on Intravenous - Year-over-year growth 2024-2029 (%)
- 8.4 Intramuscular - Market size and forecast 2024-2029
- Chart on Intramuscular - Market size and forecast 2024-2029 ($ billion)
- Data Table on Intramuscular - Market size and forecast 2024-2029 ($ billion)
- Chart on Intramuscular - Year-over-year growth 2024-2029 (%)
- Data Table on Intramuscular - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by Product
- Market opportunity by Product ($ billion)
- Data Table on Market opportunity by Product ($ billion)
9 Market Segmentation by Distribution Channel
- 9 Market Segmentation by Distribution Channel
- 9.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
- 9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 9.3 Veterinary clinics - Market size and forecast 2024-2029
- Chart on Veterinary clinics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Veterinary clinics - Market size and forecast 2024-2029 ($ billion)
- Chart on Veterinary clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Veterinary clinics - Year-over-year growth 2024-2029 (%)
- 9.4 Veterinary hospitals - Market size and forecast 2024-2029
- Chart on Veterinary hospitals - Market size and forecast 2024-2029 ($ billion)
- Data Table on Veterinary hospitals - Market size and forecast 2024-2029 ($ billion)
- Chart on Veterinary hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Veterinary hospitals - Year-over-year growth 2024-2029 (%)
- 9.5 Pharmacies and drug stores - Market size and forecast 2024-2029
- Chart on Pharmacies and drug stores - Market size and forecast 2024-2029 ($ billion)
- Data Table on Pharmacies and drug stores - Market size and forecast 2024-2029 ($ billion)
- Chart on Pharmacies and drug stores - Year-over-year growth 2024-2029 (%)
- Data Table on Pharmacies and drug stores - Year-over-year growth 2024-2029 (%)
- 9.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 9.7 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ billion)
- Data Table on Market opportunity by Distribution Channel ($ billion)
10 Market Segmentation by Route of Administration
- 10 Market Segmentation by Route of Administration
- 10.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
- 10.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- 10.3 Parenteral - Market size and forecast 2024-2029
- Chart on Parenteral - Market size and forecast 2024-2029 ($ billion)
- Data Table on Parenteral - Market size and forecast 2024-2029 ($ billion)
- Chart on Parenteral - Year-over-year growth 2024-2029 (%)
- Data Table on Parenteral - Year-over-year growth 2024-2029 (%)
- 10.4 Oral - Market size and forecast 2024-2029
- Chart on Oral - Market size and forecast 2024-2029 ($ billion)
- Data Table on Oral - Market size and forecast 2024-2029 ($ billion)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
- 10.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ billion)
- Data Table on Market opportunity by Route of Administration ($ billion)
11 Customer Landscape
- 11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 12.3.1 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 12.3.2 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 12.3.3 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ billion)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ billion)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 12.4.1 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 12.4.2 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 12.4.3 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 12.4.4 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 12.4.5 The Netherlands - Market size and forecast 2024-2029
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- 12.4.6 Spain - Market size and forecast 2024-2029
- Chart on Spain - Market size and forecast 2024-2029 ($ billion)
- Data Table on Spain - Market size and forecast 2024-2029 ($ billion)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- 12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- 12.5.1 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 12.5.2 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 12.5.3 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 12.5.4 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 12.5.5 Indonesia - Market size and forecast 2024-2029
- Chart on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- 12.6.1 Australia - Market size and forecast 2024-2029
- Chart on Australia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Australia - Market size and forecast 2024-2029 ($ billion)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- 12.6.2 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 12.6.3 Argentina - Market size and forecast 2024-2029
- Chart on Argentina - Market size and forecast 2024-2029 ($ billion)
- Data Table on Argentina - Market size and forecast 2024-2029 ($ billion)
- Chart on Argentina - Year-over-year growth 2024-2029 (%)
- Data Table on Argentina - Year-over-year growth 2024-2029 (%)
- 12.6.4 Colombia - Market size and forecast 2024-2029
- Chart on Colombia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Colombia - Market size and forecast 2024-2029 ($ billion)
- Chart on Colombia - Year-over-year growth 2024-2029 (%)
- Data Table on Colombia - Year-over-year growth 2024-2029 (%)
- 12.6.5 Saudi Arabia - Market size and forecast 2024-2029
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- 12.6.6 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ billion)
- Data Table on UAE - Market size and forecast 2024-2029 ($ billion)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- 12.6.7 South Africa - Market size and forecast 2024-2029
- Chart on South Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- 12.6.8 Israel - Market size and forecast 2024-2029
- Chart on Israel - Market size and forecast 2024-2029 ($ billion)
- Data Table on Israel - Market size and forecast 2024-2029 ($ billion)
- Chart on Israel - Year-over-year growth 2024-2029 (%)
- Data Table on Israel - Year-over-year growth 2024-2029 (%)
- 12.6.9 Turkey - Market size and forecast 2024-2029
- Chart on Turkey - Market size and forecast 2024-2029 ($ billion)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ billion)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
13 Drivers, Challenges, and Opportunity
- 13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing prevalence of porcine diseases
- Increase in research and development expenditure for development of porcine vaccines
- Growing animal healthcare expenditure
- 13.2 Market challenges
- Lack of trained veterinary doctors
- Chance of reverse reaction from vaccines
- Stringent government regulations
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities
- Growing demand for pork and gelatin
- Increasing government initiatives for funding animal husbandry sector
- Strategic initiatives by market vendors
14 Competitive Landscape
- 14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 AdvaCare Pharma
- AdvaCare Pharma - Overview
- AdvaCare Pharma - Product / Service
- AdvaCare Pharma - Key offerings
- SWOT
- 15.5 Bimeda Holdings Ltd.
- Bimeda Holdings Ltd. - Overview
- Bimeda Holdings Ltd. - Product / Service
- Bimeda Holdings Ltd. - Key offerings
- SWOT
- 15.6 Bioveta AS
- Bioveta AS - Overview
- Bioveta AS - Product / Service
- Bioveta AS - Key offerings
- SWOT
- 15.7 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
- 15.8 Ceva Sante Animale
- Ceva Sante Animale - Overview
- Ceva Sante Animale - Product / Service
- Ceva Sante Animale - Key offerings
- SWOT
- 15.9 Elanco Animal Health Inc.
- Elanco Animal Health Inc. - Overview
- Elanco Animal Health Inc. - Product / Service
- Elanco Animal Health Inc. - Key offerings
- SWOT
- 15.10 FATRO SpA
- FATRO SpA - Overview
- FATRO SpA - Product / Service
- FATRO SpA - Key offerings
- SWOT
- 15.11 Formosa Biomedical Inc.
- Formosa Biomedical Inc. - Overview
- Formosa Biomedical Inc. - Product / Service
- Formosa Biomedical Inc. - Key offerings
- SWOT
- 15.12 HIPRA SA
- HIPRA SA - Overview
- HIPRA SA - Product / Service
- HIPRA SA - Key offerings
- SWOT
- 15.13 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- 15.14 Phibro Animal Health Corp.
- Phibro Animal Health Corp. - Overview
- Phibro Animal Health Corp. - Business segments
- Phibro Animal Health Corp. - Key offerings
- Phibro Animal Health Corp. - Segment focus
- SWOT
- 15.15 Shandong Sinder Technology Co. Ltd.
- Shandong Sinder Technology Co. Ltd. - Overview
- Shandong Sinder Technology Co. Ltd. - Product / Service
- Shandong Sinder Technology Co. Ltd. - Key offerings
- SWOT
- 15.16 Vaxxinova International BV
- Vaxxinova International BV - Overview
- Vaxxinova International BV - Product / Service
- Vaxxinova International BV - Key offerings
- SWOT
- 15.17 Virbac Group
- Virbac Group - Overview
- Virbac Group - Business segments
- Virbac Group - Key offerings
- Virbac Group - Segment focus
- SWOT
- 15.18 Zoetis Inc.
- Zoetis Inc. - Overview
- Zoetis Inc. - Business segments
- Zoetis Inc. - Key news
- Zoetis Inc. - Key offerings
- Zoetis Inc. - Segment focus
- SWOT
16 Appendix
- 16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
INFORMATION SOURCES
DATA ANALYSIS
REPORT WRITING
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
